By Business/Source
Currency:USD
2024/FY
Stock NameRevenueRatio
Development of innovative ophthalmic pharmaceutical products16.02M100.00%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States16.02M100.00%